“Role of intranasal midazolam as a procedural sedative in children aged 6 months to 12 years: An open-label randomized controlled study”, Indian J Child Health, vol. 5, no. 1, pp. 1–5, Jan. 2018, doi: 10.32677/IJCH.2018.v05.i01.001.